Jane A Cauley1, Gail A Greendale, Kristine Ruppert, Yinjuan Lian, John F Randolph, Joan C Lo, Sherri-Ann Burnett-Bowie, Joel S Finkelstein. 1. Graduate School of Public Health, Department of Epidemiology (J.A.C., K.R., Y.L.), University of Pittsburgh, Pittsburgh, Pennsylvania 15261; Division of Geriatrics (G.A.G.), David Geffen School of Medicine at UCLA, Los Angeles, California 90095; Division of Reproductive Endocrinology and Infertility (J.F.R.), University of Michigan Medical School, Ann Arbor, Michigan 48109; Division of Research (J.C.L.), Kaiser Permanente Northern California, Oakland, California 94612; and Department of Medicine (S.-A.B.-B., J.S.F.), Endocrine Unit, MA General Hospital, Boston, Massachusetts 02114.
Abstract
CONTEXT: Low levels of serum 25 Hydroxyvitamin D [25(OH)D] have been linked to greater fracture risk in older women. OBJECTIVE: This study aimed to determine whether higher 25(OH)D is associated with slower loss of bone mineral density (BMD) and lower fracture risk during the menopausal transition. DESIGN, SETTING, AND PARTICIPANTS: This was a prospective cohort study at five clinical centers in the United States. Mean age was 48.5 ± 2.7 years. The fracture analysis included 124 women with an incident traumatic fracture, 88 with incident nontraumatic fracture, and 1532 women without incident fractures; average followup was 9.5 years. BMD analysis included 922 women with a documented final menstrual period. MAIN OUTCOME MEASURES: Serum 25(OH)D was measured by liquid chromatography tandem mass spectrometry at the third annual clinic visit. BMD was measured and incident fractures ascertained at each annual visit. RESULTS: The mean 25(OH)D was 21.8 ng/mL; seven-hundred two (43%) of the women had 25(OH)D values <20 ng/mL. There was no significant association between 25(OH)D and traumatic fractures. In multivariate adjusted hazards models, the hazard ratio (HR) for nontraumatic fractures (95% confidence interval [CI]) was 0.72 (0.54-0.96) for each 10-ng/mL increase in 25(OH)D. Comparing women whose 25(OH)D was ≥20 vs <20 ng/mL, the HR (95% CI) for fracture was 0.54 (0.32-0.89). Changes in lumbar spine and femoral neck bone mineral density across menopause were not significantly associated with serum 25(OH)D level. CONCLUSION: Serum 25(OH)D levels are inversely associated with nontraumatic fracture in mid-life women. Vitamin D supplementation is warranted in midlife women with 25(OH)D levels <20 ng/mL.
CONTEXT: Low levels of serum 25 Hydroxyvitamin D [25(OH)D] have been linked to greater fracture risk in older women. OBJECTIVE: This study aimed to determine whether higher 25(OH)D is associated with slower loss of bone mineral density (BMD) and lower fracture risk during the menopausal transition. DESIGN, SETTING, AND PARTICIPANTS: This was a prospective cohort study at five clinical centers in the United States. Mean age was 48.5 ± 2.7 years. The fracture analysis included 124 women with an incident traumatic fracture, 88 with incident nontraumatic fracture, and 1532 women without incident fractures; average followup was 9.5 years. BMD analysis included 922 women with a documented final menstrual period. MAIN OUTCOME MEASURES: Serum 25(OH)D was measured by liquid chromatography tandem mass spectrometry at the third annual clinic visit. BMD was measured and incident fractures ascertained at each annual visit. RESULTS: The mean 25(OH)D was 21.8 ng/mL; seven-hundred two (43%) of the women had 25(OH)D values <20 ng/mL. There was no significant association between 25(OH)D and traumatic fractures. In multivariate adjusted hazards models, the hazard ratio (HR) for nontraumatic fractures (95% confidence interval [CI]) was 0.72 (0.54-0.96) for each 10-ng/mL increase in 25(OH)D. Comparing women whose 25(OH)D was ≥20 vs <20 ng/mL, the HR (95% CI) for fracture was 0.54 (0.32-0.89). Changes in lumbar spine and femoral neck bone mineral density across menopause were not significantly associated with serum 25(OH)D level. CONCLUSION: Serum 25(OH)D levels are inversely associated with nontraumatic fracture in mid-life women. Vitamin D supplementation is warranted in midlife women with 25(OH)D levels <20 ng/mL.
Authors: Håkan Melhus; Greta Snellman; Rolf Gedeborg; Liisa Byberg; Lars Berglund; Hans Mallmin; Per Hellman; Rune Blomhoff; Emil Hagström; Johan Arnlöv; Karl Michaëlsson Journal: J Clin Endocrinol Metab Date: 2010-03-23 Impact factor: 5.958
Authors: Andrew W Roddam; Rachel Neale; Paul Appleby; Naomi E Allen; Sarah Tipper; Timothy J Key Journal: Am J Epidemiol Date: 2007-08-22 Impact factor: 4.897
Authors: Elizabeth A Platz; Michael F Leitzmann; Bruce W Hollis; Walter C Willett; Edward Giovannucci Journal: Cancer Causes Control Date: 2004-04 Impact factor: 2.506
Authors: P Pramyothin; S Techasurungkul; J Lin; H Wang; A Shah; P D Ross; R Puapong; R D Wasnich Journal: Osteoporos Int Date: 2009-03-24 Impact factor: 4.507
Authors: Jane A Cauley; Neeta Parimi; Kristine E Ensrud; Douglas C Bauer; Peggy M Cawthon; Steven R Cummings; Andrew R Hoffman; James M Shikany; Elizabeth Barrett-Connor; Eric Orwoll Journal: J Bone Miner Res Date: 2010-03 Impact factor: 6.741
Authors: Deborah M Mitchell; Kristin Ruppert; Nisha Udupa; Fatima Bassir; Karin Darakananda; Daniel H Solomon; Yinjuan Lian; Jane A Cauley; Arun S Karlamangla; Gail A Greendale; Joel S Finkelstein; Sherri-Ann M Burnett-Bowie Journal: Clin Endocrinol (Oxf) Date: 2019-04-24 Impact factor: 3.478
Authors: Jane A Cauley; Michelle E Danielson; Guru Rajesh Jammy; Doug C Bauer; Rebecca Jackson; Jean Wactawski-Wende; Rowan T Chlebowski; Kristine E Ensrud; Robert Boudreau Journal: J Clin Endocrinol Metab Date: 2017-05-01 Impact factor: 5.958
Authors: Po-Yin Chang; Ellen B Gold; Jane A Cauley; Wesley O Johnson; Carrie Karvonen-Gutierrez; Elizabeth A Jackson; Kristine M Ruppert; Jennifer S Lee Journal: J Clin Endocrinol Metab Date: 2016-06-13 Impact factor: 5.958